In order to understand the effect of CR on CD8+ T cell-dependent anti-tumor immune responses, we next examined the population of TILs in B16-OVA tumor-bearing mice fed with the control diet or the CR diet, and with or without anti-PD-1 Ab treatment. This evidence concerns the gene CD8A and neoplasm.